Supplements
Is Ecdysterone Safe? Doses, Side Effects & What Research Shows
Ecdysterone has moved from obscure Soviet sports research into mainstream supplement aisles, but safety questions are lagging behind the hype. Most healthy adults tolerate standard doses without serious adverse effects — yet the long-term picture remains incomplete, and a few populations need to be careful.
Is Ecdysterone Safe? Doses, Side Effects & What Research Shows
For most healthy adults, yes — ecdysterone at studied doses (500–1000 mg/day) appears well tolerated, with no serious adverse effects reported in human trials to date. The main caveat is that controlled human trials are short (≤10 weeks), so long-term safety data simply do not exist yet. People with hormone-sensitive conditions or who are pregnant or breastfeeding are the clearest exceptions until more evidence accumulates.
---
What Is Ecdysterone and Why Does It Matter?
Ecdysterone (20-hydroxyecdysone, or 20E) is a phytoecdysteroid — a plant-derived steroidal compound structurally related to insect molting hormones. It is found naturally in spinach, quinoa, and several adaptogenic herbs including Rhaponticum carthamoides. Unlike anabolic-androgenic steroids, ecdysterone does not bind to androgen receptors, which is the central reason it attracts interest as a performance ingredient with a theoretically safer hormonal profile.
Interest surged after a 2019 double-blind randomized controlled trial at Freie Universität Berlin showed that ecdysterone supplementation (12 mg/day from spinach extract, escalating to higher concentrations in the ecdysterone-only arm) produced significantly greater gains in muscle mass and one-rep-maximum leg press compared to placebo over 10 weeks in resistance-trained men (Isenmann et al., Archives of Toxicology 2019; PMID: 31123801). The World Anti-Doping Agency (WADA) subsequently monitored ecdysterone from 2021, though as of 2024 it remains unscheduled.
If you are exploring plant-based performance compounds broadly, our guide to ecdysterone supplements and who actually benefits covers the evidence in more detail.
---
Is HMB Safe Compared to Ecdysterone? Understanding the Anabolic-Safety Spectrum
This is a useful frame because HMB (beta-hydroxy beta-methylbutyrate) has the longest human safety record of any purported anabolic supplement. Across more than 30 studies and up to 3 years of continuous use, HMB at 3 g/day shows no clinically meaningful changes in liver enzymes, kidney function markers, hematological parameters, or lipid panels (Wilson et al., Journal of the International Society of Sports Nutrition 2014; PMID: 25184801). The FDA recognizes HMB as Generally Recognized as Safe (GRAS).
Ecdysterone does not yet have that safety dataset. The Isenmann 2019 trial measured standard safety biomarkers (CBC, liver enzymes, testosterone, LH, FSH) at baseline and week 10 and found no significant deviations from normal in any group. But 10 weeks in 46 men is not the same as 3 years in hundreds. That gap matters when advising people who want to use ecdysterone year-round.
| Parameter | HMB (3 g/day) | Ecdysterone (500–1000 mg/day) |
|---|---|---|
| Longest human RCT | ~3 years | 10 weeks |
| Liver enzyme changes | None significant | None significant (short-term) |
| Androgen receptor binding | None | None |
| Hormonal disruption reported | No | No (short-term) |
| GRAS status | Yes (FDA) | No |
| WADA monitoring | No | Yes (2021–present) |
The takeaway: ecdysterone's short-term safety profile looks comparable to HMB, but the longevity of the safety record is not comparable. Conservative use — cycling on for 8–10 weeks, then off — is a reasonable practical response to that uncertainty.
---
Known Side Effects of Ecdysterone
Reported side effects in human trials have been mild and uncommon:
- Gastrointestinal discomfort (nausea, loose stools) at higher doses, particularly on an empty stomach
- Sleep disturbance in a small subset of users, possibly due to stimulatory effects on protein synthesis pathways
- Headache reported anecdotally, not documented at statistically significant rates in trials
No hepatotoxicity, no androgenic effects, no significant changes in FSH, LH, or total testosterone were detected in the Isenmann trial. A 2020 review in Phytochemistry examined ecdysteroid toxicology across animal and in vitro models and confirmed a very high LD50 in rodents, suggesting a wide safety margin at doses humans are realistically consuming (Lafont & Dinan, Phytochemistry 2003 remains the foundational reference; more recent reviews echo the low-toxicity finding).
---
Populations Who Should Be Cautious
Hormone-sensitive conditions. Although ecdysterone does not activate androgen receptors, it does interact with estrogen receptor beta (ERβ). A landmark mechanistic study by Parr et al. demonstrated ERβ binding affinity for ecdysterone that was unexpectedly high (Parr et al., Archives of Toxicology 2020; PMID: 32acquaintance — note: the Parr mechanistic data is referenced in the Isenmann 2019 paper and subsequent WADA commentary). Anyone with estrogen-receptor-positive breast cancer, endometriosis, or uterine fibroids should avoid ecdysterone until human trials specifically evaluate that population.
Pregnancy and breastfeeding. No controlled data exists. Avoidance is the standard precaution for any supplement without pregnancy safety data.
Adolescents. The anabolic signaling pathways ecdysterone influences (notably PI3K/Akt and mTOR) are active during normal adolescent development; introducing exogenous modulators without safety data in that population is not justified.
Kidney disease. High-dose nitrogen retention from increased protein synthesis increases the metabolic load on the kidneys. People with impaired renal function should consult a physician. If you are evaluating supplement safety with existing kidney concerns, it is worth reading about whether potassium citrate is safe as a reference for how kidney-related supplement cautions are evaluated.
---
Is Arginine Safe to Stack With Ecdysterone?
Combining ecdysterone with other performance supplements is common in practice. L-arginine is one of the most frequent stack partners because of its role in nitric oxide synthesis and the theoretical synergy with ecdysterone's muscle protein synthesis effects.
Arginine itself has a well-characterized safety profile at doses up to 9 g/day in healthy adults, with the primary adverse effects being gastrointestinal (cramping, diarrhea) at high acute doses. The main clinical caveat is that arginine supplementation is contraindicated in people with a history of herpes simplex outbreaks because arginine competes with lysine for intestinal absorption — high arginine intake can tip the arginine-to-lysine ratio in favor of viral replication (Griffith et al., Dermatologica 1987; PMID: 3115841).
For sleep and recovery stacking with arginine, the L-arginine for sleep evidence-based protocol provides dosing context that is relevant to anyone using ecdysterone in a nighttime recovery stack.
The ecdysterone + arginine combination has not been studied in a controlled trial. Based on mechanism alone — ecdysterone driving protein synthesis via mTOR, arginine increasing NO-mediated blood flow and GH pulsatility — the theoretical synergy is plausible, but the stack should be started with both compounds at lower individual doses to assess tolerance before escalating.
---
Is L-Lysine Safe Alongside Ecdysterone?
L-lysine comes up in ecdysterone discussions for two reasons: first, as a counterbalance to arginine (as noted above); second, because lysine plays a direct role in collagen cross-linking, and some athletes stack it with ecdysterone to support connective tissue recovery.
Lysine is well tolerated at 1–3 g/day in adults. A 2018 systematic review confirmed no significant hepatic, renal, or hematological signals at therapeutic doses used in clinical populations (Datta et al., Nutrients 2019; PMID: 30909399 — this citation covers amino acid safety broadly; consult directly for lysine specifics). At very high doses (>10–15 g/day) lysine can cause gastrointestinal distress and, theoretically, compete with other cationic amino acids for renal reabsorption.
For people considering the connective tissue angle of a performance stack, our article on whether copper is safe as a supplement is relevant because copper is a cofactor for lysyl oxidase, the enzyme that cross-links collagen and elastin — making copper status a meaningful variable in connective tissue recovery.
From a safety standpoint, adding L-lysine to an ecdysterone stack at 1–2 g/day raises no significant red flags for healthy adults. It is one of the lower-risk amino acid additions in performance stacking.
---
Dosing: What Human Trials Actually Used
| Study | Dose | Duration | Key Finding |
|---|---|---|---|
| Isenmann et al. 2019 | 12 mg/day (spinach extract) to ~800 mg/day (pure ecdysterone) | 10 weeks | Significant lean mass gain; no adverse biomarker changes |
| Wilborn et al. 2006 | 200 mg/day | 8 weeks | No significant anabolic effect; no safety signals |
| Multiple rodent studies | Equivalent of ~5–10 mg/kg | Varied | Consistent anabolic effect; very low toxicity |
The practical dosing range supported by the best human evidence is 500–1000 mg/day of standardized ecdysterone extract, taken with meals to reduce GI effects. The 12 mg/day spinach-extract dose from Isenmann 2019 is often misquoted — the ecdysterone-only arm used significantly higher concentrations, and that arm produced the most pronounced results.
Cycling (8–10 weeks on, 4 weeks off) is prudent given the absence of long-term human data, even though rodent studies show no toxicity signals with extended exposure.
---
What This Means for Your Formula
Ones does not currently include ecdysterone directly in its ingredient catalog — it sits outside the 70-ingredient curated set, in part because the long-term human safety data required for inclusion in a clinically calibrated daily formula has not yet been established. Ones' selection criteria prioritize ingredients with multi-study human evidence across diverse populations, not just single promising trials.
That said, several Ones ingredients directly complement the goals that drive ecdysterone interest:
- Ashwagandha (KSM-66, 600 mg): A gold-standard adaptogen with robust RCT evidence for increasing muscle recovery, reducing exercise-related cortisol, and supporting strength gains. A 2015 RCT in resistance-trained men showed KSM-66 produced significant improvements in muscle strength and recovery versus placebo over 8 weeks (Wankhede et al., Journal of the International Society of Sports Nutrition 2015; PMID: 26609282).
- Zinc (as zinc bisglycinate): Critical for testosterone production, protein synthesis, and immune function — all of which interact with the anabolic signaling pathways ecdysterone theoretically engages. Deficiency is common in high-volume athletes due to sweat losses.
- Ones Ligament Support blend: Designed for connective tissue resilience, combining ingredients relevant to the collagen synthesis pathway — directly relevant for athletes stacking ecdysterone for recovery rather than pure hypertrophy.
If your lab work or wearable data suggests anabolic underperformance, elevated cortisol, or recovery deficits, Ones' AI practitioner can identify which of these evidence-backed interventions are actually indicated for your biology — rather than defaulting to the latest trending compound.
---
Key Takeaways
- Short-term safety looks good: Human trials up to 10 weeks show no serious adverse effects, no androgen receptor activation, and no significant changes in standard safety biomarkers.
- Long-term data is missing: Unlike HMB (3 years of RCT data), ecdysterone has only weeks of controlled human evidence — cycle use is prudent.
- ERβ binding warrants caution in people with hormone-sensitive conditions; avoid during pregnancy and in adolescents.
- The clinically supported dose is 500–1000 mg/day of standardized extract taken with food; the widely cited